逸飛激光(688646.SH):整體來看公司訂單較為充裕
格隆匯10月19日丨逸飛激光(688646.SH)接受特定對象調研時表示,今年以來,公司強化市場導向的產品策略,加大重點市場開拓。在電芯設備領域,公司以圓柱全極耳電芯裝備為核心,實現對主要客户和產品結構的全面覆蓋,並推動了傳統小圓柱電池全極耳化改造升級和大圓柱鈉電池的產業應用;在模組 PACK 設備領域,公司針對模組 PACK 市場多元化需求特徵,進行了針對性的產品定位,推出了高柔性的激光焊接站、多兼容的儲能電池模組 PACK 生產線等產品,在國內外市場取得了良好的市場口碑。整體來看,公司訂單較為充裕。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.